ArticleJournal of neuroinflammation2024

Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways.

Julie Langlois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.